Global Venous Thromboembolism Therapeutics Market Analysis, Trends, Market Size & Forecasts up to 2024, With an Expected CAGR of 3.7% - ResearchAndMarkets.com

DUBLIN--()--The "Venous Thromboembolism Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global venous thromboembolism therapeutics market to grow with a CAGR of 3.7% over the forecast period of 2018-2024.

Key factors responsible for the growth of this market includes, development of anticoagulants that are used to prevent the formation of new blood clots and to treat existing clots by preventing them from growing larger in size. It also reduces the risk of embolization of blood clots to other vital organs such as the lungs and brain. Also growing geriatric population and rise in incidence rate of venous thromboembolism will boost the market growth. High treatment cost and side effects associated with VTE drugs hinders the market growth. Increase patient awareness concerning VTE treatment may create lucrative opportunities in near future.

On the basis of region, the Venous Thromboembolism Therapeutics market is divided into North America, Europe, Asia pacific, and the Rest of the World (RoW). North America region is the leading region in the venous thromboembolism therapeutics market. Increase adoption for advance treatment and rising geriatric population are some of the factors responsible for driving growth in this region. Asia Pacific region is an emerging market for venous thromboembolism therapeutics due to the developing healthcare infrastructure and rising government expenditure in the healthcare industry.

The report on venous thromboembolism therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global venous thromboembolism therapeutics market over the period of 2016 to 2024.

Companies Mentioned

  • Bayer HealthCare
  • Boehringer Ingelheim
  • BMS
  • Daiichi Sankyo
  • Sanofi
  • Johnson & Johnson
  • Aspen Pharma
  • BioInvent International
  • eXIthera Pharmaceuticals
  • Gamma Therapeutics

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Venous Thromboembolism Therapeutics Market Overview

4. Global Venous Thromboembolism Therapeutics Market by Drug Class

5. Global Venous Thromboembolism Therapeutics Market by Region 2018-2024

6. Company Covered

For more information about this report visit https://www.researchandmarkets.com/research/kp9fr6/global_venous?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs